Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines

22 Sept 2011

Abstract excerpt

BACKGROUND: Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide. According to the National Cancer Institute, ovarian cancer has the highest mortality rate among all the reproductive cancers in women. Advanced stage diagnosis and chemo/radio-resistance is a major obstacle in treating advanced ovarian cancer. The most commonly employed chemotherapeutic drug for ovarian cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21939554
DOI: 10.1186/1757-2215-4-17

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell linesPMID 21939554Read ↗

The role of microRNA in cisplatin resistance or sensitivitySemantic proximity Read ↗

Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patientsSemantic proximity Read ↗

The significance of microRNA genes expression in ovarian cancer cell lines resistant to cytotoxic drugsSemantic proximity Read ↗

Ovarian Cancer—Insights into Platinum Resistance and Overcoming ItSemantic proximity Read ↗

Long Noncoding RNAs as Biotargets in Cisplatin-Based Drug ResistanceSemantic proximity Read ↗

Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patientsSemantic proximity Read ↗

Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic ApproachSemantic proximity Read ↗

DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian CancerSemantic proximity Read ↗

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwaySemantic proximity Read ↗

Deciphering the role of miR-506 in ovarian cancer drug sensitivitySemantic proximity Read ↗

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.